Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea
· Delayed Price · Currency is KRW 14,020
0.00 (0.00%)
At close: Dec 5, 2025
Cell Biotech Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 15,156 | 4,757 | 7,884 | 8,458 | 9,860 | 9,600 | Upgrade
|
| Short-Term Investments | 68,094 | 74,450 | 56,515 | 37,671 | 18,675 | 23,084 | Upgrade
|
| Trading Asset Securities | 5,708 | 8,247 | 5,933 | 19,239 | 29,299 | 22,203 | Upgrade
|
| Cash & Short-Term Investments | 88,958 | 87,454 | 70,332 | 65,368 | 57,834 | 54,887 | Upgrade
|
| Cash Growth | 11.68% | 24.34% | 7.59% | 13.03% | 5.37% | -7.32% | Upgrade
|
| Accounts Receivable | 4,759 | 3,991 | 4,595 | 4,566 | 4,664 | 4,835 | Upgrade
|
| Other Receivables | 1,579 | 682.88 | 943.86 | 583.11 | 268.43 | 283.39 | Upgrade
|
| Receivables | 6,624 | 4,976 | 5,740 | 5,330 | 5,216 | 5,557 | Upgrade
|
| Inventory | 4,488 | 4,203 | 4,122 | 4,102 | 3,589 | 3,503 | Upgrade
|
| Prepaid Expenses | 718.99 | 287.27 | 691.85 | 500.5 | 292.5 | 218.67 | Upgrade
|
| Other Current Assets | 297.58 | 228.19 | 1,044 | 354.58 | 587.81 | 746.72 | Upgrade
|
| Total Current Assets | 101,087 | 97,148 | 81,929 | 75,655 | 67,519 | 64,913 | Upgrade
|
| Property, Plant & Equipment | 30,929 | 30,463 | 32,937 | 33,638 | 34,057 | 36,602 | Upgrade
|
| Long-Term Investments | 501.94 | 501.94 | 501.94 | 3,786 | 8,427 | 2 | Upgrade
|
| Other Intangible Assets | 1,392 | 1,606 | 1,599 | 1,793 | 1,536 | 1,802 | Upgrade
|
| Long-Term Accounts Receivable | -0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Long-Term Deferred Tax Assets | 216.96 | 216.96 | 182.29 | 449.3 | 751.56 | 1,395 | Upgrade
|
| Other Long-Term Assets | 447.37 | 461.66 | 491.37 | 517.21 | 585.15 | 587.54 | Upgrade
|
| Total Assets | 134,574 | 130,398 | 117,641 | 115,839 | 112,877 | 105,301 | Upgrade
|
| Accounts Payable | 818.17 | 680.27 | 578.39 | 1,370 | 1,224 | 887.65 | Upgrade
|
| Accrued Expenses | 1,287 | 481.51 | 489.15 | 443.91 | 470.95 | 496.32 | Upgrade
|
| Current Portion of Leases | 481.73 | 650.28 | 621.14 | 600.78 | 402.89 | 658.65 | Upgrade
|
| Current Income Taxes Payable | 627.24 | 1,404 | - | 1,038 | 814.73 | - | Upgrade
|
| Current Unearned Revenue | 22.42 | 27.57 | 27.03 | 30.9 | 50.44 | 41.52 | Upgrade
|
| Other Current Liabilities | 4,129 | 2,619 | 3,106 | 3,905 | 2,802 | 2,546 | Upgrade
|
| Total Current Liabilities | 7,366 | 5,863 | 4,821 | 7,389 | 5,766 | 4,630 | Upgrade
|
| Long-Term Leases | 95.39 | 366.66 | 934.17 | 357.79 | 423.49 | 686.44 | Upgrade
|
| Other Long-Term Liabilities | -0 | - | - | - | 0 | - | Upgrade
|
| Total Liabilities | 7,461 | 6,229 | 5,755 | 7,747 | 6,189 | 5,317 | Upgrade
|
| Common Stock | 4,700 | 4,700 | 4,700 | 4,700 | 4,700 | 4,700 | Upgrade
|
| Additional Paid-In Capital | 12,760 | 12,760 | 12,760 | 12,760 | 12,760 | 12,760 | Upgrade
|
| Retained Earnings | 132,916 | 130,264 | 118,217 | 114,993 | 109,894 | 102,696 | Upgrade
|
| Treasury Stock | -23,978 | -23,978 | -23,978 | -23,978 | -20,258 | -20,258 | Upgrade
|
| Comprehensive Income & Other | 714.32 | 422.69 | 186.4 | -382.91 | -408.42 | 86.97 | Upgrade
|
| Shareholders' Equity | 127,113 | 124,168 | 111,885 | 108,092 | 106,687 | 99,985 | Upgrade
|
| Total Liabilities & Equity | 134,574 | 130,398 | 117,641 | 115,839 | 112,877 | 105,301 | Upgrade
|
| Total Debt | 577.11 | 1,017 | 1,555 | 958.57 | 826.38 | 1,345 | Upgrade
|
| Net Cash (Debt) | 88,381 | 86,437 | 68,777 | 64,409 | 57,007 | 53,542 | Upgrade
|
| Net Cash Growth | 12.63% | 25.68% | 6.78% | 12.98% | 6.47% | -8.16% | Upgrade
|
| Net Cash Per Share | 12918.81 | 12629.74 | 10049.37 | 9342.06 | 8061.43 | 7547.42 | Upgrade
|
| Filing Date Shares Outstanding | 6.84 | 6.84 | 6.84 | 6.84 | 7.07 | 7.07 | Upgrade
|
| Total Common Shares Outstanding | 6.84 | 6.84 | 6.84 | 6.84 | 7.07 | 7.09 | Upgrade
|
| Working Capital | 93,721 | 91,286 | 77,108 | 68,266 | 61,754 | 60,283 | Upgrade
|
| Book Value Per Share | 18575.08 | 18142.94 | 16348.17 | 15793.91 | 15086.68 | 14094.07 | Upgrade
|
| Tangible Book Value | 125,721 | 122,563 | 110,286 | 106,299 | 105,151 | 98,183 | Upgrade
|
| Tangible Book Value Per Share | 18371.71 | 17908.31 | 16114.53 | 15531.88 | 14869.49 | 13840.05 | Upgrade
|
| Land | 9,696 | 9,696 | 9,765 | 9,765 | 9,765 | 9,784 | Upgrade
|
| Buildings | 22,074 | 19,675 | 19,537 | 13,349 | 13,854 | 14,389 | Upgrade
|
| Machinery | 25,506 | 25,847 | 25,644 | 7,228 | 8,033 | 9,682 | Upgrade
|
| Construction In Progress | 128.92 | 385.42 | 338.95 | 993.9 | 247.26 | 95 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.